Author/Creator: Martinowitz, U. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Martinowitz, U.

1. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high‐responding inhibitors – a thrombin generation‐guided pilot study. (10th May 2013)

Authors:: Livnat, T.; Martinowitz, U.; Azar‐Avivi, S.; Zivelin, A.; Brutman‐Barazani, T.; Lubetsky, A.; Kenet, G.
Journal:: Haemophilia
Issue:: Volume 19:Number 5(2013:Sep.)
Page Start:: 782
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three‐times‐weekly prophylaxis with rFVIII‐FS. (20th November 2013)

Authors:: Lalezari, S.; Martinowitz, U.; Windyga, J.; Enriquez, M. M.; Delesen, H.; Schwartz, L.; Scharrer, I.
Journal:: Haemophilia
Issue:: Volume 20:Number 1(2014:Jan.)
Page Start:: e15
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Genetic polymorphism of IL28B in hepatitis C‐infected haemophilia patients in Israel. (23rd August 2012)

Authors:: Maor, Y.; Morali, G.; Bashari, D.; Pénaranda, G.; Schapiro, J. M.; Martinowitz, U.; Halfon, P.
Journal:: Haemophilia
Issue:: Volume 19:Number 1(2013:Jan.)
Page Start:: 150
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage. (29th October 2015)

Authors:: White, N. J.; Mehic, E.; Wang, X.; Chien, D.; Lim, E.; St. John, A. E.; Stern, S. A.; Mourad, P. D.; Rieger, M.; Fries, D.; Martinowitz, U.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 13:Number 12(2015:Dec.)
Page Start:: 2202
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. (7th May 2013)

Authors:: Lentz, S. R.; Misgav, M.; Ozelo, M.; Šalek, S. Z.; Veljkovic, D.; Recht, M.; Cerqueira, M.; Tiede, A.; Brand, B.; Mancuso, M. E.; Seremetis, S.; Lindblom, A.; Martinowitz, U.
Journal:: Haemophilia
Issue:: Volume 19:Number 5(2013:Sep.)
Page Start:: 691
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Results of a phase I/II open‐label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients. (20th May 2015)

Authors:: Martinowitz, U.; Lissitchkov, T.; Lubetsky, A.; Jotov, G.; Barazani‐Brutman, T.; Voigt, C.; Jacobs, I.; Wuerfel, T.; Santagostino, E.
Journal:: Haemophilia
Issue:: Volume 21:Number 6(2015:Nov.)
Page Start:: 784
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin‐ activatable fibrinolysis inhibitor. (4th February 2015)

Authors:: Shenkman, B.; Einav, Y.; Livnat, T.; Budnik, I.; Martinowitz, U.
Journal:: International journal of laboratory hematology
Issue:: Volume 37:Number 4(2015:Aug.)
Page Start:: 521
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗